Maple Leaf Green World Inc. (OTCMKTS:MGWFF) has announced that it has received approval from THC testing from the California Department of Food & Agriculture. The state of California mandated THC testing seeks to ensure that the tested crop doesn’t exceed the recommended legal THC limit of 0.3%.
CDFA approval for Le Crème Hemp products
A pre-harvest THC testing component involves random samples taken by the agricultural commissioner from any of Maple Leaf Green’s five greenhouses or outdoor grow for lab testing. If the THC tests results exceed the 0.3% limit, it will lead to an immediate implementation of a corrective action plan that will result in significant harvesting delays. The company has reported that the CDFA lab report tested THC levels that were less than 0.3%. Following the CDFA approval, the company can now sell the La Crème Hemp products.
Maple Leaf Green continues to harvest and cure La Crème. The COA sample collected on October 2, 2020, continues to indicate a pure CBG flower with a 15.44% increase in CBG concentration from the previous COA sample at 13.9%. The CBG level is higher than most market strains, and it is marketable, but the company is targeting the 18-20% range for its fully cured flower.
No cannabinoids found in the COA sample
The COA sample indicated THC levels of 0.07%, and there were no other cannabinoids found. It is important to note that sometimes the samples would have traces of cannabinoids as enzymes breakdown CBGa to produce the cannabinoids. But a lack of the cannabinoids is an indication of pure CBG flower.
The outdoor crop is also showing large buds and is projected to produce 2-3 lbs of flower per plant. With the company preparing for the first harvest with clones cut to set up for a second harvest, and when the flowers mature fully, they will achieve CBG of 18%. Raymond Lai, the CEO of the company, said that they are delighted with the first harvest. He said that the low THC nature of the strain offered the flexibility of the vegetating stage.